The instructive role of innate immunity in the acquired immune response DT Fearon, RM Locksley Science 272 (5258), 50-54, 1996 | 2472 | 1996 |
T cell exclusion, immune privilege, and the tumor microenvironment JA Joyce, DT Fearon Science 348 (6230), 74-80, 2015 | 1766 | 2015 |
A framework for advancing our understanding of cancer-associated fibroblasts E Sahai, I Astsaturov, E Cukierman, DG DeNardo, M Egeblad, RM Evans, ... Nature Reviews Cancer 20 (3), 174-186, 2020 | 1738 | 2020 |
Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer C Feig, JO Jones, M Kraman, RJB Wells, A Deonarine, DS Chan, ... Proceedings of the National Academy of Sciences 110 (50), 20212-20217, 2013 | 1565 | 2013 |
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer D Öhlund, A Handly-Santana, G Biffi, E Elyada, AS Almeida, ... Journal of Experimental Medicine 214 (3), 579-596, 2017 | 1564 | 2017 |
C3d of complement as a molecular adjuvant: bridging innate and acquired immunity PW Dempsey, MED Allison, S Akkaraju, CC Goodnow, DT Fearon Science 271 (5247), 348-350, 1996 | 1498 | 1996 |
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. JD Fingeroth, JJ Weis, TF Tedder, JL Strominger, PA Biro, DT Fearon Proceedings of the National Academy of Sciences 81 (14), 4510-4514, 1984 | 1262 | 1984 |
Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis HF Weisman, T Bartow, MK Leppo, HC Marsh Jr, GR Carson, MF Concino, ... Science 249 (4965), 146-151, 1990 | 1222 | 1990 |
Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein–α M Kraman, PJ Bambrough, JN Arnold, EW Roberts, L Magiera, JO Jones, ... Science 330 (6005), 827-830, 2010 | 1064 | 2010 |
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice J Albrengues, MA Shields, D Ng, CG Park, A Ambrico, ME Poindexter, ... Science 361 (6409), eaao4227, 2018 | 856 | 2018 |
Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte DT Fearon The Journal of experimental medicine 152 (1), 20-30, 1980 | 850 | 1980 |
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer VP Balachandran, M Łuksza, JN Zhao, V Makarov, JA Moral, R Remark, ... Nature 551 (7681), 512-516, 2017 | 846 | 2017 |
CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes RH Carter, DT Fearon Science 256 (5053), 105-107, 1992 | 835 | 1992 |
Control of the amplification convertase of complement by the plasma protein beta1H. JM Weiler, MR Daha, KF Austen, DT Fearon Proceedings of the National Academy of Sciences 73 (9), 3268-3272, 1976 | 743 | 1976 |
Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. A Nicholson-Weller, J Burge, DT Fearon, PF Weller, KF Austen Journal of immunology (Baltimore, Md.: 1950) 129 (1), 184-189, 1982 | 695 | 1982 |
A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP GM Doody, LB Justement, CC Delibrias, RJ Matthews, J Lin, ML Thomas, ... Science 269 (5221), 242-244, 1995 | 624 | 1995 |
Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. DT Fearon, KF Austen The Journal of experimental medicine 142 (4), 856-863, 1975 | 623 | 1975 |
Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis J Tanner, J Weis, D Fearon, Y Whang, E Kieff Cell 50 (2), 203-213, 1987 | 614 | 1987 |
Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21) JM Ahearn, DT Fearon Advances in immunology 46, 183-219, 1989 | 593 | 1989 |
Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex DT Fearon, MC Carroll, MC Carroll Annual review of immunology 18 (1), 393-422, 2000 | 581 | 2000 |